First blood test to diagnose bipolar disorder A team involving researchers from Alcediag, Montpellier University Hospital, Les Toises Psychiatry Centre in Lausanne and Professor David J. Kupfer from the University of Pittsburgh identified and validated a combination of blood biomarkers specific to bipolar disorder. These results, recently published in Nature,…..
New perspective on RNA function: RNA regulates proteins and thereby can control cell growth Scientists are increasingly learning of new reasons to appreciate RNA, and the glycolytic enzyme ENO1 seems to have provided yet another in new research from European Molecular Biology Laboratory (EMBL) this week, as published in Molecular…..
New solution for stem cell manufacturing Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost. [caption id="attachment_10614" align="aligncenter" width="700"] Modular 3D printed microfluidic system©Majid Warkiani et al. Bioresources…..
Coriolis Pharma creates a new campus in Martinsried-Munich Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new campus as the next step…..
Early signs support revolutionary potential of EU clinical trials regulation The EU Clinical Trials Regulation should help resolve problems caused by its predecessor directive and help meet needs arising from the pandemic. There will be challenges in doing so, but there is already strong evidence of the benefits awaiting. Evidence…..
EUROAPI supports Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles EUROAPI, the European CDMO announced by Sanofi in February 2020, has expanded its collaboration with the French group under the umbrella of their Master Agreement for Development and GMP Manufacturing Services, dated October 1, 2021, to support…..
Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market Arrowhead Pharmaceuticals, a US company focused on therapies triggering the RNA interference (RNAi), and Vivo Capital, a global healthcare investment firm with offices in Palo Alto, CA, and in China, have formed a new joint venture, Visirna…..
New data-driven approach to help reduce drug costs and treat diseases A new data-driven mechanistic approach that predicts cell types within tissue will help to reduce drug costs and treat diseases that were difficult to develop drugs for, according to a West Virginia University scientist. [caption id="attachment_10508" align="aligncenter" width="700"] WVU…..
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies TreeFrog Therapeutics, a French-based biotech company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), announced the incorporation of its Japanese subsidiary…..
Novasep, a major CDMO focused on complex small molecules and antibody-drug conjugates (ADCs), and PharmaZell, a leading supplier of highly resilient and specialty APIs, have just closed their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, leading Franco-German CDMO and API manufacturer. Novasep’s…..